Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of ...

Each year, the Christodoula March stands as a historic symbol of solidarity with those navigating cancer. An event offering ...

The National Comprehensive Cancer Network® (NCCN®) and the NCCN Foundation® proudly announce four recipients for the 2025 NCCN Foundation Young Investigator Awards (YIA). These awards provide ...

The Global Excellence Awards, a prestigious ceremony dedicated to recognising outstanding achievements across various industries worldwide, is set to take place on 5th April, 2025 in Le ...

A new suggestion that complexity increases over time, not just in living organisms but in the nonliving world, promises to ...

Remaining $60 Million of outstanding convertible notes to be repurchased post-close of pending UDENYCA divestiture – REDWOOD CITY, Calif., ...

The delisting decision comes as a significant setback for Aptose, which was unable to meet the Nasdaq’s equity rule by the March 31 deadline, marking the limit of the Panel’s discretion to allow ...

It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over ...

It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism ...

Odd Burger Corporation ("Odd Burger" or the "Company") , a leading vegan fast-food restaurant chain and food technology company, is pleased to announce the appointment of Graham Taylor, a leading ...

It began trading independently on the New York Stock Exchange on the 2nd January under the symbol "ABBV ... immunology, oncology, renal disease and women's health. Some of its current pipeline ...